Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations

DTG/3TC showed high efficacy in participants with tRAMs not affecting this regimen. The detection of such tRAMs did not compromise treatment outcomes in treatment-naïve individuals in this setting.

Authors

Institutions

Publication Details

Journal
AIDS
Published
2026-01-15
DOI
https://doi.org/10.1097/qad.0000000000004444
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations

Gisela Arevalo Calderon, Ezequiel Córdova, Soledad Seleme, Norma Porteiro et al.
AIDS
HIV/AIDS drug development and treatment
article

Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations

Gisela Arevalo Calderon, Ezequiel Córdova, Soledad Seleme, Norma Porteiro, Veronica Mingrone, Jenifer Hernandez Rendon
article en

Abstract

DTG/3TC showed high efficacy in participants with tRAMs not affecting this regimen. The detection of such tRAMs did not compromise treatment outcomes in treatment-naïve individuals in this setting.

AIDS
Fundación para la Investigación, Docencia y Prevención del Cáncer (AR)
Good health and well-being
Openalex Percentile: Top 84%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations — Gisela Arevalo Calderon, Ezequiel Córdova, et al. · AIDS (2026) | TGRS Research Map | TGRS